Aqueous Interleukin-6 (IL-6) Level Is a Marker for Treatment Resistance to Bevacizumab in Age-Related Macular Degeneration —Aqueous Cytokines after Bevacizumab
Kakarla V. Chalam, Sandeep Grover, Sankarathi Balaiya, Ravi K. Murthy

Open J. Ophthalmol. Vol.4 No.1, February 13, 2014
DOI:10.4236/ojoph.2014.41005

Hepcidin Prohormone Levels in Patients with Primary Open-Angle Glaucoma
Asaad A. Ghanem, Salah E. Mady, Tarek N. Attia, Lamiaa F. Arafa

Open J. Ophthalmol. Vol.4 No.1, February 13, 2014
DOI:10.4236/ojoph.2014.41004

Variations of Cup-to-Disc Ratio in Children
Sherif Ahmed Kamel Amer, Mohamed Yasser Sayed Saif, Ahmed Tamer Sayed Saif, Passant Sayed Saif

Open J. Ophthalmol. Vol.4 No.1, February 10, 2014
DOI:10.4236/ojoph.2014.41003

Intravitreal Bevacizumab with Grid Photocoagulation for Recurrent Macular Edema Secondary to Retinal Vein Occlusion
Salah M. Mady, Asaad A. Ghanem

Open J. Ophthalmol. Vol.4 No.1, February 10, 2014
DOI:10.4236/ojoph.2014.41002

Optic Nerve Head Drusen, Myopia and Ocular Hypertension: A Case Report
Arzu Taskiran Comez, Baris Komur

Open J. Ophthalmol. Vol.4 No.1, January 26, 2014
DOI:10.4236/ojoph.2014.41001